Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United ...

Gland Pharma receives USFDA approval for Latanoprost Ophthalmic Solution, strengthening its position in the US pharmaceutical ...

The uptick in Gland Pharma share came after the company said that it has received approval from the United States Food and ...

Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:40 Hrs [IST] Gland Pharma, a generic injectable–focused pharmaceut ...

Background: Although in vitro and in vivo laboratory studies have suggested that benzalkonium chloride (BAK) in topical ophthalmic solutions ... preservative systems: latanoprost 0.005% with ...

Latanoprost ophthalmic solution 0.005% with 0.02% BAK or travoprost 0.004% ophthalmic solution with sofZia were tested against the following bacteria and fungi: Staphylococcus aureus (ATCC 6538 ...

Gland Pharma added 1.23% to Rs 1,801.35 after the drug manufacturer received approval from the United States Food and Drug Administration (USFDA) for Latanoprost Ophthalmic Solution.

Latanoprost Ophthalmic Solution is used for treatment of high eye pressure, or intraocular pressure (IOP) in patients with ...